GURU.Markets stock price, segment price, and overall market index valuation
The company's share price ThermoGenesis
The shares of ThermoGenesis, a company developing cell therapy technologies, reflect its struggle for commercialization. Their price trajectory is volatile and depends on news about equipment sales and the need for additional funding.
Share prices of companies in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and manufactures automated stem cell processing and storage equipment for the cell and gene therapy market. We've categorized it as "Diagnostic Medical Equipment." The chart below shows the dynamics of the regenerative medicine technology sector.
Broad Market Index - GURU.Markets
ThermoGenesis develops and manufactures automated equipment for processing and storing umbilical cord blood stem cells. As a leader in its niche, it is included in our GURU.Markets index. The chart below shows the overall market trend. Compare it with ThermoGenesis' performance.
Change in the price of a company, segment, and market as a whole per day
THMO - Daily change in the company's share price ThermoGenesis
ThermoGenesis Holdings, Inc.'s daily price change reflects volatility in the cell therapy sector. The metric demonstrates sensitivity to demand for its biomaterial processing and storage equipment.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and markets automated processing and storage equipment for cell and gene therapy products. The chart below shows volatility in the medical device sector, allowing us to assess how the market is responding to THMO technologies.
Daily change in the price of a broad market stock, index - GURU.Markets
ThermoGenesis produces equipment for the automated processing and storage of cellular products, such as stem cells. This medtech company's stock performance is driven by investments in regenerative medicine. Its history reflects the contribution of innovative medicine to overall volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization ThermoGenesis
ThermoGenesis Holdings' year-over-year performance tells the story of its performance in the cell therapy market. Its market capitalization over the past 12 months reflects demand for its stem cell processing and storage equipment, as well as its success in providing contract manufacturing (CDMO) services to biotech companies.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
ThermoGenesis is a company specializing in stem cell processing and storage technologies. This chart illustrates how its niche business, reliance on R&D budgets, and competition in the rapidly evolving field of cell therapy influence its volatile performance.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
ThermoGenesis, with its cell therapy equipment, is an "infrastructure" bet on biotech. Its performance relative to the market is a barometer of activity in the regenerative medicine sector. The industry's growth is driving increased demand for its automated systems.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization ThermoGenesis
ThermoGenesis produces equipment for stem cell processing and storage. Its monthly sales are driven by demand from stem cell banks and biotech companies. Quarterly sales reports are key.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
ThermoGenesis develops and manufactures automated equipment for processing and storing stem cells used in cell therapy and regenerative medicine. The chart below shows the dynamics of the medical equipment sector, where the company is a key supplier of tools for advanced medicine.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
ThermoGenesis develops equipment for automated stem cell processing and storage. Demand for its products depends on activity in the cell therapy and regenerative medicine sectors. Its shares move with the biotech innovation cycle, not the broader market.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization ThermoGenesis
The weekly performance of ThermoGenesis, a company that produces cell therapy equipment, reflects the infrastructure of the sector. Its stock price is responding to demand from biotech companies for their automated systems for processing and storing cell products.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
ThermoGenesis develops and sells equipment for automated stem cell processing and storage. This chart compares its weekly performance with the industry and helps understand how the market values its niche products amid the growth of the cell therapy and regenerative medicine industries.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
ThermoGenesis is a medical technology company. Shares of such companies may be less dependent on general economic cycles. This chart will help us understand whether ThermoGenesis shares are living in a world of clinical trials, or whether the overall market environment still influences their stock price.
Market capitalization of the company, segment and market as a whole
THMO - Market capitalization of the company ThermoGenesis
ThermoGenesis's market capitalization tells the story of a company that produces equipment for stem cell processing and storage. Its chart tells the story of a niche but important segment of the biotech industry. Its dynamics reflect the market's assessment of its technology and demand from stem cell banks and research centers.
THMO - Share of the company's market capitalization ThermoGenesis within the market segment - Diagnostic medical equipment
ThermoGenesis Holdings supplies automated systems for stem cell processing and storage. Its small share of its segment's market capitalization reflects its narrow technological niche. The chart below shows how the market views its role in the growing cell therapy industry.
Market capitalization of the market segment - Diagnostic medical equipment
ThermoGenesis is a company developing equipment for automated stem cell processing and storage. The chart below shows the market capitalization of the biotech sector. Its dynamics provide the backdrop against which ThermoGenesis offers its niche solutions for the growing cell therapy market.
Market capitalization of all companies included in a broad market index - GURU.Markets
ThermoGenesis is a company developing technologies for processing and storing stem cells. Its market cap is a bet on the future of regenerative medicine. Its performance on the overall chart reflects how the market evaluates the potential of technologies that could underpin the medicine of the future.
Book value capitalization of the company, segment and market as a whole
THMO - Book value capitalization of the company ThermoGenesis
ThermoGenesis's foundation is its capital and production capacity for automated stem cell processing and storage systems. This represents real, technological capital for the cell therapy and regenerative medicine industries. How has this niche medical technology asset evolved? The chart below shows its dynamics.
THMO - Share of the company's book capitalization ThermoGenesis within the market segment - Diagnostic medical equipment
ThermoGenesis produces equipment for automated stem cell processing and storage. The chart shows the share of its manufacturing assets, reflecting its physical scale in building infrastructure for cell therapy and regenerative medicine.
Market segment balance sheet capitalization - Diagnostic medical equipment
ThermoGenesis, a manufacturer of cell therapy equipment, is a moderately capital-intensive business. It requires R&D and manufacturing capabilities. The BCap_Seg chart for the medical equipment sector shows that creating the hardware for the medicine of the future requires a material base.
Book value of all companies included in the broad market index - GURU.Markets
ThermoGenesis' assets include its technology and manufactured equipment for automated stem cell processing and storage (e.g., the AXP system). Its balance sheet reflects its patents and manufacturing capabilities. The chart shows the material weight of this player in the cell therapy market.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - ThermoGenesis
ThermoGenesis produces equipment for stem cell processing and storage. Its balance sheet is based on its patents and production capacity. Its market capitalization is an estimate of its technologies and the demand for them from stem cell banks and regenerative medicine research centers.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
ThermoGenesis Holdings provides automated technologies for processing and storing stem cells used in cell therapy. Its market valuation on the chart reflects its niche technological position in this advanced medical market, not just the value of its production equipment.
Market to book capitalization ratio for the market as a whole
ThermoGenesis Holdings develops cell therapy equipment. It's a business that combines manufacturing and high technology. The market values it as a supplier of tools for the growing biotech industry. The chart helps understand how these infrastructure companies for the future of medicine are valued.
Debts of the company, segment and market as a whole
THMO - Company debts ThermoGenesis
ThermoGenesis, a company that produces equipment for automated processing and storage of cellular products (such as stem cells), uses capital for R&D and commercialization. This chart shows how the cell therapy company is funding its technologies, aiming to become a key supplier for biobanks and regenerative medicine.
Market segment debts - Diagnostic medical equipment
ThermoGenesis develops and markets automated processing and storage equipment for cell and gene therapies. This chart illustrates how a small, advanced medical device company is funding its operations and carving out a niche in the rapidly growing regenerative medicine market.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio ThermoGenesis
ThermoGenesis develops and manufactures equipment for automated stem cell processing and storage. This chart shows how the company uses debt to finance its development and production in the niche bioprocessing market. It helps assess its financial strategy and sustainability.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
ThermoGenesis provides automated systems for processing and storing stem cells, primarily from umbilical cord blood. This represents a niche segment of the biotech equipment market. The chart shows debt trends in the sector, helping to understand how the company finances its specialized technologies.
Debt to book value of all companies in the market
ThermoGenesis Holdings develops technologies for stem cell processing and storage, a niche but important segment in biotechnology. This chart, showing the overall market debt burden, helps assess the company's financial policies. It provides insight into how this specialized equipment manufacturer finances its developments.
P/E of the company, segment and market as a whole
P/E - ThermoGenesis
ThermoGenesis Holdings develops and sells automated stem cell processing and storage equipment for the cell therapy market. This chart shows the market valuation of its niche medical devices. The dynamics reflect the growth of the regenerative medicine industry and the demand for its technologies.
P/E of the market segment - Diagnostic medical equipment
This chart shows the average P/E ratio for diagnostic equipment manufacturers. For ThermoGenesis, this is an important benchmark. It helps understand how investors value its niche cell therapy products compared to larger, more diversified medical device companies.
P/E of the market as a whole
ThermoGenesis is a company developing equipment for automated stem cell processing and storage. Its valuation is a bet on the growth of the cell therapy and regenerative medicine market. Its valuation is not tied to general economic cycles, but depends on the adoption of its technologies in clinical practice and research laboratories.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company ThermoGenesis
For ThermoGenesis Holdings, Inc., a company that manufactures stem cell processing and storage equipment, this chart illustrates market expectations for future sales. It reflects forecasts for cell therapy market growth and the company's ability to deliver its solutions to this sector.
%20P%2FE%20ThermoGenesis&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-ThermoGenesis&v=1772513473994 "Chart of the company's future (projected) P/E ThermoGenesis")
Future (projected) P/E of the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and markets automated equipment for processing and storing cord blood stem cells and other cellular products. The chart shows forecasts for the medical device sector. This helps assess how the market perceives ThermoGenesis's niche position in the growing field of cell therapy and regenerative medicine.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Diagnostic-medical-equipment&v=1772513474016 "Future (projected) P/E graph of the market segment - Diagnostic medical equipment")
Future (projected) P/E of the market as a whole
ThermoGenesis Holdings, Inc. manufactures equipment for automated processing and storage of cell products. The company operates in the cell therapy market. Demand for its products depends on the growth of this industry. This chart of overall biotech risk appetite indirectly indicates the expected growth of its clients.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772513474024 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit ThermoGenesis
ThermoGenesis Holdings develops and sells automated systems for stem cell processing and storage. The company's profits depend on sales of its equipment to cell therapy centers and cord blood banks. This chart illustrates the company's performance in the niche but growing regenerative medicine market.
Profit of companies in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and markets automated equipment for stem cell processing and storage. This graph, which displays sector profitability, illustrates the growing regenerative medicine market. Their systems are used in cord blood banks and research laboratories, ensuring high quality and efficiency in processing cellular products.
Overall market profit
ThermoGenesis Holdings develops and markets equipment for automated stem cell processing and storage. The company operates in the niche cell therapy market. Demand for its products depends on activity in this cutting-edge field of medicine. Economic growth, reflected in this graph, stimulates investment in biotechnology, which benefits ThermoGenesis.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company ThermoGenesis
ThermoGenesis Holdings provides automated technologies for processing and storing umbilical cord blood stem cells. This chart reflects analysts' forecasts for growth in the cell therapy market and cord blood banks, where the company's equipment is used to ensure quality and efficiency.
%20profit%20of%20the%20company%20ThermoGenesis&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-ThermoGenesis&v=1772513474399 "Graph of future (projected) profit of the company ThermoGenesis")
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and markets automated cell processing and storage equipment for the cell therapy market. The company's growth depends on the development of regenerative medicine. This chart for the medical device sector reflects expected growth in the market for cell and gene therapy tools and technologies.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Diagnostic-medical-equipment&v=1772513474471 "Graph of future (predicted) profits of companies in a market segment - Diagnostic medical equipment")
Future (predicted) profit of the market as a whole
ThermoGenesis develops equipment for processing and storing stem cells. Demand for its products depends on the development of cell therapy and regenerative medicine. This schedule, reflecting general economic expectations, influences the amount of funding allocated to these cutting-edge scientific fields.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772513474538 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - ThermoGenesis
ThermoGenesis Holdings develops and sells automated systems for stem cell processing and storage. The chart below shows how investors value its revenue. It reflects demand for its equipment from cord blood banks and research centers, as well as growth potential in the field of regenerative medicine.
P/S market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and sells automated stem cell processing and storage systems for the cell therapy market. The company's revenue depends on the adoption of its technologies in biobanks and clinical laboratories. This chart, which reflects the average valuation in the sector, helps understand how investors value ThermoGenesis's equipment.
P/S of the market as a whole
ThermoGenesis Holdings develops and sells automated stem cell processing and storage equipment for the cell therapy market. This chart, showing average market revenue estimates, helps understand how investors value this equipment provider in the rapidly growing but still evolving regenerative medicine industry.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company ThermoGenesis
ThermoGenesis Holdings develops and sells automated equipment for processing and storing stem cells used in cell therapy. It is a niche player in the biotechnology market. This chart reflects investor expectations for the future growth of the cell therapy market and demand for its specialized equipment.
%20P%2FS%20ThermoGenesis&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-ThermoGenesis&v=1772513474712 "The graph of the company's future (projected) P/S ThermoGenesis")
Future (projected) P/S of the market segment - Diagnostic medical equipment
ThermoGenesis Holdings, Inc. is a company developing and commercializing automated technologies for the processing and storage of cell and gene therapies. This chart shows the average estimated future sales in the medical device sector. It helps understand how the market views ThermoGenesis's role in the growing field of regenerative medicine.
%20P%2FS%20market%20segment%20graph%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Diagnostic-medical-equipment&v=1772513474749 "Future (projected) P/S market segment graph - Diagnostic medical equipment")
Future (projected) P/S of the market as a whole
ThermoGenesis Holdings develops and markets automated equipment for processing and storing stem cells for cell therapy. This chart shows overall market revenue forecasts. The company's products are a vital part of the infrastructure for the emerging field of regenerative medicine, and demand for them is growing alongside the industry.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772513474824 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales ThermoGenesis
This chart shows the revenue of ThermoGenesis, a company that develops and sells automated systems for processing and storing cells used in cell and gene therapy. Sales reflect demand for its equipment from biobanks, research centers, and biotech companies.
Sales of companies in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and manufactures automated cell processing and storage equipment for the cell and gene therapy market. This chart illustrates the growth of the biotechnology equipment market. The company's products are a critical part of the infrastructure for developing advanced treatments, ensuring their quality and scalability.
Overall market sales
ThermoGenesis Holdings develops and manufactures equipment for the automated processing and storage of cellular products (such as stem cells). Demand for its products depends on the development of regenerative medicine. This total revenue chart reflects the economic climate, which influences biotechnology investment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company ThermoGenesis
ThermoGenesis develops and markets automated cell processing and storage systems, which are critical to the cell and gene therapy market. Future revenues depend on the growth of this cutting-edge field of medicine. The chart below shows the biomanufacturing market forecast.
%20sales%20of%20the%20company%20ThermoGenesis&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-ThermoGenesis&v=1772513475004 "Schedule of future (projected) sales of the company ThermoGenesis")
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and manufactures automated stem cell processing and storage equipment for the cell therapy market. Its products are used in cord blood banks and research laboratories. This chart shows the forecast for the entire diagnostic and biotechnology equipment market, where ThermoGenesis occupies a niche.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Diagnostic-medical-equipment&v=1772513475032 "Schedule of future (projected) sales of companies in the market segment - Diagnostic medical equipment")
Future (projected) sales of the market as a whole
ThermoGenesis develops and markets automated cell processing and storage equipment for the cell and gene therapy market. Demand for their products depends on the growth of this industry. This graph, reflecting investment in regenerative medicine, is an indicator of how aggressively companies will build the production facilities that require their equipment.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772513475056 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality ThermoGenesis
ThermoGenesis develops and markets equipment for the automated processing and storage of cellular products used in cell therapy. The company's profitability depends on the growth of the regenerative medicine industry. This chart shows the financial results of the company, which provides critical tools to biotech companies and stem cell banks.
Market segment marginality - Diagnostic medical equipment
ThermoGenesis develops and markets automated equipment for the processing and storage of cell and gene therapies. Profitability depends on the growth of the regenerative medicine industry and the adoption of their systems as a standard. This chart shows their operating results as a supplier of key tools for biomedical development.
Market marginality as a whole
ThermoGenesis Holdings is a company that provides automated technologies for processing and storing stem cells, primarily from umbilical cord blood. Their equipment is used in cell therapy. This overall profitability chart is not as important for them. Their growth depends on the development of the cell therapy market and the number of cord blood banks they serve.
Employees in the company, segment and market as a whole
Number of employees in the company ThermoGenesis
ThermoGenesis develops and markets automated cell processing and storage equipment for cell therapy. The company operates with a small, dedicated team. This chart reflects its focus on the niche but growing market of regenerative medicine tools.
Share of the company's employees ThermoGenesis within the market segment - Diagnostic medical equipment
ThermoGenesis Holdings develops and markets automated equipment for processing and storing cells used in cell therapy. This chart reflects its niche expertise. It shows the size of the team that creates and advances technologies critical to stem cell banks and companies developing advanced treatments.
Number of employees in the market segment - Diagnostic medical equipment
ThermoGenesis Holdings, Inc. is a company developing and commercializing automated cell processing and storage technologies for the cell and gene therapy market. This chart illustrates employment trends in the biotechnology equipment sector. The growth in the number of engineers here reflects the growing need for standardized and efficient tools for the production of advanced drugs.
Number of employees in the market as a whole
ThermoGenesis Holdings supplies equipment for automated stem cell processing and storage. Demand for its products is driven by advances in cell therapy and regenerative medicine. Overall economic growth, as illustrated by this chart, supports investment in these advanced healthcare areas by hospitals and biotech companies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company ThermoGenesis (THMO)
ThermoGenesis develops and sells equipment for automated stem cell processing and storage (biobanking). This is a niche sector of MedTech. The chart shows the market value of their patented technologies and market share. The high cost per employee reflects that they sell complex, capital-intensive equipment, not just services.
%20of%20the%20company%20ThermoGenesis%20(THMO)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-ThermoGenesis-THMO&v=1772513475433 "Chart of market capitalization per employee (in thousands of dollars) of the company ThermoGenesis (THMO)")
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
ThermoGenesis develops and markets automated equipment for processing and storing cells used in cell therapy. It creates tools for the biotechnology industry. This chart shows how the market values its proprietary equipment and its role in the growing regenerative medicine sector.
%20by%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Diagnostic-medical-equipment&v=1772513475454 "Market capitalization per employee (in thousands of dollars) by market segment - Diagnostic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
ThermoGenesis develops and markets automated equipment for the processing and storage of cell and gene therapies. The chart shows its valuation in the Life Science sector. It reflects how the team creates value by providing tools that are critical to advanced drugmakers.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772513475568 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company ThermoGenesis (THMO)
ThermoGenesis manufactures and sells automated equipment for processing and storing stem cells (for example, from umbilical cord blood) and for use in cell therapy. It's a "shovel business" for regenerative medicine. This chart shows how successfully the company sells these expensive devices and their consumables.
%20Chart%20ThermoGenesis%20(THMO)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-ThermoGenesis-THMO&v=1772513475582 "Company Profit Per Employee (in thousands of dollars) Chart ThermoGenesis (THMO)")
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
ThermoGenesis is a company that produces automated equipment for stem cell processing and storage for the cell and gene therapy market. It is a niche medical equipment business. This metric reflects how successfully the company can sell its systems to biobanks and laboratories.
%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Diagnostic-medical-equipment&v=1772513475633 "Chart of profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
ThermoGenesis (THMO) is a medical technology company that produces equipment for automated stem cell processing and storage (cell therapy). It is a niche B2B hardware manufacturer. This chart shows the demand (margin) for their equipment among biotech companies and blood banks.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772513475655 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee ThermoGenesis (THMO)
ThermoGenesis Holdings provides automated technologies for processing and storing cells for cell and gene therapy. This chart shows the demand for its equipment. The increase in revenue per employee indicates the implementation of its systems by biobanks and biotech companies, improving their efficiency.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-ThermoGenesis-THMO&v=1772513475664 "Sales chart per company employee ThermoGenesis (THMO)")
Sales per employee in the market segment - Diagnostic medical equipment
ThermoGenesis (THMO) produces automated cell processing and storage equipment, which is crucial for cord blood banks and cell therapy developers. This chart shows how much revenue each employee (engineer, salesperson) generates from sales of these specialized medical devices.
Sales per employee for the market as a whole
ThermoGenesis (THMO) produces equipment for automated stem cell processing and storage (cell therapy). It is a niche B2B medical equipment manufacturer. This chart shows how efficiently the company utilizes its staff to produce and sell its specialized equipment to biotech companies and blood banks.
Short shares by company, segment and market as a whole
Shares shorted by company ThermoGenesis (THMO)
ThermoGenesis produces cell processing and storage equipment, used, for example, in cord blood banks. The bearish sentiment shown in this chart reflects investors' bets that this is a very niche and low-growth market, and that the company will not achieve profitability.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-ThermoGenesis-THMO&v=1772513475760 "Short Shares Chart for the Company ThermoGenesis (THMO)")
Shares shorted by market segment - Diagnostic medical equipment
ThermoGenesis (THMO) specializes in automated cell processing and storage technologies critical for cell therapies (e.g., CAR-T) and stem cell banking. This chart shows overall bearish bets against the biotech equipment sector. A high reading suggests investors expect a slowdown in R&D or commercialization of cell-based therapies.
Shares shorted by the overall market
ThermoGenesis is a microcap company that supplies stem cell processing and cell therapy equipment. This chart illustrates the general fear. When investors are afraid, they sell off illiquid shares. They also worry that ThermoGenesis's clients (biotech companies) will cut R&D budgets during a recession, which will hurt demand for their niche equipment.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator ThermoGenesis (THMO)
ThermoGenesis (THMO) produces equipment for the automated processing and storage of stem cells (for example, from umbilical cord blood). It's a niche biotech market. This oscillator measures the strength of speculative moves. It shows when the stock is "overheated" (above 70) due to contract news or "oversold" (below 30) due to a lack of demand.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-ThermoGenesis-THMO&v=1772513475828 "RSI 14 indicator chart for the company's stock ThermoGenesis (THMO)")
RSI 14 Market Segment - Diagnostic medical equipment
ThermoGenesis is a "tool" for *cell therapy*. They make *automated* equipment (AXP, PXP) for *processing* and *cryostorage* of *stem cells* (from umbilical cord blood). The "Diagnostic medical equipment" (medtech) sector thrives on R&D. RSI_14_Seg shows whether the *entire* sector is "overbought." This helps to differentiate: is the growth of THMO their "niche" or the *general* "hype"?
RSI 14 for the overall market
ThermoGenesis (THMO) is a cash-burning biotech. This chart is its lifeline. During periods of market euphoria, investors are willing to "buy the dream" and fund unprofitable R&D projects. During moments of panic, the cash flow is turned off, and investors demand profits rather than promises, putting THMO's survival at risk.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast THMO (ThermoGenesis)
ThermoGenesis is a company that supplies cell therapy equipment, specifically automated systems (X-Series) for stem cell processing and storage. This chart shows the analysts' average 12-month forecast. It reflects their outlook on growth in the regenerative medicine sector and demand for their equipment.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-THMO-ThermoGenesis&v=1772513475890 "A chart showing analyst consensus forecasts for the expected stock price. THMO (ThermoGenesis)")
The difference between the consensus estimate and the actual stock price THMO (ThermoGenesis)
ThermoGenesis (THMO) is the "automation" of cell therapy. The company produces equipment (CAR-TXpress) to automate and reduce the cost of CAR-T production in laboratories. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and the forecast, reflecting their confidence in this "B2B hardware" for biotech.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-THMO-ThermoGenesis&v=1772513475907 "A chart showing the difference between the consensus forecast and the actual stock price. THMO (ThermoGenesis)")
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
ThermoGenesis is a cell therapy "bank." The company produces automated equipment (X-Series) for contract manufacturers (CDMOs) that helps them process and store stem cells. This chart shows general expectations for the diagnostic equipment sector. It reflects whether experts believe cell therapy "outsourcing" will grow.
Analysts' consensus forecast for the overall market share price
ThermoGenesis (THMO) is a cell processor. They produce consumable equipment for biotech, helping labs and hospitals automatically process and store stem cells. This chart shows the overall risk appetite. It reflects the level of confidence analysts have in the R&D budgets of Big Pharma, THMO's clients.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index ThermoGenesis
ThermoGenesis provides automated equipment for processing and storing stem cells and other cellular products (blood banking, cell therapy). This is a niche medical equipment market. This chart is a composite index assessing the speed of adoption of their systems in research and clinical centers, as well as their ability to compete in the niche bioprocessing market.
AKIMA Market Segment Index - Diagnostic medical equipment
ThermoGenesis (THMO) is a cell diagnostic medical device company. They produce automated systems for processing and storing stem cells (from umbilical cord blood). This chart compares their composite index to the medtech sector average.
The AKIM Index for the overall market
ThermoGenesis is a company providing automated cell processing (CAR-TXpress) and biobanking services. This chart, which reflects the market average, is a backdrop. It helps assess how THMO, a technology partner in cell therapy, stacks up against the backdrop of overall macroeconomic fluctuations.
